FBXW7 and chronic myelogenous leukemia, BCR-ABL1 positive: In a mouse model of CML, ablation of Fbxw7 induced long-term stem cells to enter the cell cycle, and Fbxw7-deficient leukemia stem cells were sensitized to Ara-C and imatinib (Takeishi et al., 2013).